The global wound care devices market size was valued at USD 2883.11 million in 2025 and is projected to grow from USD 3031.88 million in 2026 to USD 4534.36 million by 2034 at a CAGR of 5.16% during the forecast period 2026-2034.
The major factors contributing to the growth of wound care devices industry are increasing prevalence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, associated with growing aging population worldwide. In addition, technological advancements in developing more user-friendly, portable wound care device along with digital monitoring solutions are enhancing treatment effectiveness and patient comfort, thus driving better patient compliance and higher adoption rates. Further, growing focus on evidence-based clinical and multidisciplinary wound care treatment, contribute to innovation and accessibility, thereby positioning wound care device a critical component in addressing the global burden of chronic wounds.
Source: International Diabetes Federation, World Health Organization (WHO), and Straits Research
An emerging trend in the wound care industry is the shift toward patient-centered care, emphasizing convenience, comfort, and greater autonomy. This trend has accelerated the development of user-friendly and portable wound care devices that support at-home management and improve patient adherence.
Instillation NPWT Device Manufacturers and Their Core Capabilities
Manufacturer
Product
Key Features (Therapy Modes)
Solventum
3M Veraflo Therapy
· Instillation therapy
· Continuous therapy
Guangzhou Rainhome Pharm & Tech Co., Ltd.
Instill negative pressure wound therapy machine
· Dynamic therapy
· Intermittent therapy
· Cleansing wound therapy
CONFORT
C500 NPWT Therapy Unit
· Interval therapy
· Instillation intermittent therapy
Source: Company Product Portfolio, and Straits Research
Thus, such innovations enhance the overall patient experience along with reducing the burden on healthcare facilities by limiting in-person visits and enabling remote wound monitoring, thereby propelling the broader shift towards decentralized care.
The growing adoption of telemedicine and digital health technologies is transforming the chronic wound care segment by enabling remote monitoring and management of wounds. These solutions enhance access and ensure continuity of care, which is especially important for patients with chronic wounds. The COVID-19 pandemic further accelerated this trend by emphasizing the necessity of remote healthcare delivery.
Examples of Digital Health Integration in Wound Care
Company
Solution
Key Features
Swift Medical Inc.
Swift Skin and Wound
AI-powered remote wound assessment via smartphone images.
Net Health
WoundExpert EHR
AI-driven wound tracking integrated with clinical workflows.
eKare Inc.
Insight 3D Wound Imaging System
3D wound measurement and analytics with telehealth integration.
Healthy.io
Minuteful for Wound
Smartphone-based wound assessment with AI-powered imaging and remote monitoring.
Adiuvo Diagnostics
Illuminate
AI-driven hyperspectral imaging device for rapid, non-invasive wound infection detection.
KroniKare Pte Ltd
KroniKare Wound Scanner
Portable multi-spectral device for automated wound assessment and monitoring.
Source: Company Product Portfolios, Straits Research
Thus, the rise in remote wound management is boosting demand for smart wound care devices such as integrated NPWT systems, sensor-based dressings, and home-use monitoring tools thereby, supporting decentralized, patient-centric care.
Download Free Sample Report to Get Detailed Insights.
The rise in chronic conditions such as diabetes, obesity, and vascular diseases is leading to a higher incidence of slow-healing wounds.
Source: International Diabetes Federation, World Health Organization (WHO), and Straits Research (* indicate projections)
Further, according to the International Diabetes Federation, diabetes-related neuropathy affects approximately 1 in 2 people living with diabetes, significantly increasing the risk of chronic wounds. These wounds often require long-term, advanced care solutions such as NPWT devices, hyperbaric oxygen therapy systems, and electrical stimulation devices.
Thus, as the global chronic disease burden grows, so does the need for efficient wound care technologies to manage complications and improve patient outcomes.
Reimbursement schemes are a key factor driving the adoption and growth of advanced wound care devices. By providing financial coverage for costly treatments, these schemes help reduce economic barriers and encourage healthcare providers to incorporate innovative technologies such as negative pressure wound therapy (NPWT).
Medicare Reimbursement Rates for Pensar Medical’s NPWT Device
Product Name
End User
Procedure Code
Description
2025 MPFS Allowable
Rates Non-Facility ($)
Rates Facility ($)
tNPWT
Hospital Outpatient
97605
NPWT for wounds ≤ 50 cm²
42.05
23.61
Physicians / QHPs
97606
NPWT for wounds > 50 cm²
50.14
25.55
sNPWT
97607
399.53
97608
323.14
20.38
337.05
Home Healthcare
A9272
NPWT for wounds
276.57
Source: U.S. Centers for Medicare & Medicaid Services, Pensar Medical Reimbursement Guidelines, and Straits Research
Thus, this structured reimbursement enables wider adoption by lowering treatment costs for providers and patients.
The widespread use of advanced wound care products such as antimicrobial dressings, bioengineered skin substitutes, and topical growth factors presents a restraint for device-based therapies such as NPWT, oxygen therapy systems, and electric stimulation devices. These alternatives are often easier to apply, require less specialized equipment, and are more cost-effective, especially in outpatient or home care settings.
Thus, clinicians may prefer these non-device options over complex wound care devices, slowing the adoption and market penetration of wound care devices.
The increasing number of specialized wound care clinics presents a significant opportunity for growth in the wound care devices market, as these clinics focus exclusively on treating complex and chronic wounds using advanced protocols.
This growth leads to several key opportunities:
Thus, the expansion of specialized wound care clinics offers opportunities for innovation, product diversification, and faster market growth.
The market is segmented into negative pressure wound therapy, oxygen and hyperbaric oxygen equipment, electric stimulation devices and others. Negative pressure wound therapy segment accounted for largest wound care devices market share, owing to increasing clinical acceptance of NPWT devices, growing recommendation for instillation negative pressure wound therapy by physicians, surge in prevalence of diabetic foot ulcers, and investments in the development of advanced NPWT devices are the major factors driving the segment growth.
The market is segmented into chronic wounds, and acute wounds. Chronic wounds segment dominated the wound care sector and is expected to register fastest CAGR during the forecast period. This growth is driven by growing awareness about chronic wound management, increasing prevalence of chronic venous insufficiencies and pressure ulcers, and surge in aging population that are more susceptible to developing pressure injuries.
Further, the chronic wound segment is segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others. The pressure ulcers segment is expected to register fastest CAGR during the forecast period, owing to a rise in incidences of pressure ulcers among long-term care facilities, high cost of treatment due to prolonged hospital stays, and increasing burden of vascular and neurological disorders that are highly prone to develop pressure ulcers.
Furthermore, the acute wound segment is divided into surgical & traumatic wounds, and burns. Surgical & traumatic wounds segment accounted for largest share, owing to high volume of surgical procedures, increasing incidences of road accidents, and adoption of wound care devices for the management of surgical and traumatic wounds.
The market is segmented into hospitals, home care settings, wound care centers, and others. Home care settings segment is anticipated to register fastest CAGR during the forecast period owing to increasing demand for convenient, cost-effective wound care solutions, growing preference for at-home treatment among patients, advancements in portable and user-friendly wound care devices, rising prevalence of chronic wounds requiring long-term management, and supportive reimbursement policies encouraging home-based care.
North America accounted for the largest share of the wound care devices market, with 38.01% of the revenue, owing to strong healthcare infrastructure, high adoption of advanced technologies such as NPWT, well-established reimbursement schemes, and increasing prevalence of chronic wounds and diabetes. Additionally, rising awareness about effective wound management and substantial investments in healthcare innovation further drive market growth in the region.
Source: Articles, Government Publications, and Straits Research
Asia Pacific region is anticipated to grow at fastest CAGR of 6.80% during the forecast period. This growth is driven by increasing prevalence of chronic conditions such as diabetes and obesity which significantly contribute to diabetic foot ulcers and pressure ulcers. Furthermore, rising incidences of trauma and accidents, rising number of patentable wound care products, and the availability of advanced wound care products to treat diabetic foot ulcers collectively drive the regional market growth.
Source: Population Reference Bureau, Worldometer, and Straits Research
Key Government and Collaborative Initiatives for Wound Care Management in Australia
Initiative / Program
Objective
Wound Management Pilot
Govt-funded pilot under Primary Health Care Development Program
Test and implement effective wound care models in primary healthcare
MBS Review Taskforce: Wound Management Working Group
Recommendations to improve wound care, support bulk billing reforms
Improve GP-delivered wound care and propose new funding models
AHRA Wound Care Initiative
MRFF-funded projects targeting wound care standards and research
Update standards, training, cost analysis, and coordinated research
Connected Wound Care (Victoria)
Collaboration to address wound care practice gaps
Standardize wound care and improve specialist access
Wounds West
WA-based collaboration for sustainable wound care
Online education, digital imaging, data collection, prevalence studies
Wound Management Innovation CRC
$28M initiative for research and solution development
Innovate in wound care technology, training, and clinical trials
Digital Wound ID Solution (Coviu)
AI-enabled mobile imaging for telehealth wound assessments
Enable remote wound monitoring in aged care via AI
Wounds Australia 11-Point Plan
National policy blueprint for training, funding, and reforms
Advocate systemic improvements in wound care nationwide
NSW Health LBVC: Chronic Wound Management
LBVC program to standardize care and integrate services
Promote holistic and coordinated chronic wound care
5-Point Plan for Wound Management
National initiative to enhance chronic wound care
Boost access, awareness, training, and research in wound management
Source: Australian Medical Association, Wounds Australia, and Straits Research
Key players in the industry are focus on adopting key business strategies, such as product launches, acquisitions, and product approvals, to gain a strong foothold in the market.
Accel-Heal Technologies Limited is an emerging player in the market, owing to its innovative wound care solutions and expanding market presence.
Recent developments by Accel-Heal Technologies Limited:
The wound care devices market is witnessing significant growth, driven by the rising prevalence of chronic wounds and diabetes, increased adoption of advanced technologies such as negative pressure wound therapy (NPWT), a growing aging population, improved reimbursement policies that make treatments more accessible, and heightened awareness among healthcare providers and patients about the importance of effective wound management.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Jay Mehta is a Research Analyst with over 4 years of experience in the Medical Devices industry. His expertise spans market sizing, technology assessment, and competitive analysis. Jay’s research supports manufacturers, investors, and healthcare providers in understanding device innovations, regulatory landscapes, and emerging market opportunities worldwide.
We are featured on:
sales@straitsresearch.com